Up a level |
Dhandapany, PS and Kang, S and Kashyap, DK and Rajagopal, R and Sundaresan, NR and Singh, R and Thangaraj, K and Jayaprakash, S and Manjunath, CN and Shenthar, J and Lebeche, D (2021) Adiponectin receptor 1 variants contribute to hypertrophic cardiomyopathy that can be reversed by rapamycin. In: Science Advances, 7 (2).